Advancing Diagnostic Precision in the US Mycoplasma Testing Market
In recent years, the US mycoplasma testing market has demonstrated impressive momentum, with its size projected to reach approximately USD 1,529.59 million by 2035. This escalation is driven by technological advancements in testing methodologies and a notable increase in the demand for quality assurance within the biopharmaceutical sector. As mycoplasma contamination poses a significant risk to...
0 Comments 0 Shares 39 Views 0 Reviews